Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2021-11-29 00:00:00 ET · period of report 2021-11-24 · accession 0001209191-21-067067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-29 | 2021-11-24 | MIRM | Peetz Christopher | Pres, CEO, Dir | P - Purchase | $14.40 | +7,000 | 28.0K | +33% | +$100.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-24 | P | A | 7,000 | $14.40 | 28,027 | D | — | — |